Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Herpes Simplex Keratitis at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Herpes Simplex Keratitis Session

Herpes simplex keratitis (HSK) is a common viral infection affecting the cornea, caused by the herpes simplex virus (HSV). It typically presents with symptoms such as pain, redness, tearing, blurred vision, and sensitivity to light. HSK can lead to corneal scarring and vision loss if not promptly treated. Diagnosis involves a thorough eye examination by an ophthalmologist, often including a slit-lamp examination to assess the corneal surface. Treatment aims to reduce inflammation and control viral replication. This typically includes antiviral medications such as topical or oral acyclovir, as well as corticosteroids to manage inflammation. Long-term management may involve antiviral prophylaxis to prevent recurrence and protect vision. Patients with HSK require regular follow-up to monitor for complications and ensure timely intervention if symptoms worsen or recur. Early detection and treatment are crucial in managing HSK effectively and preserving visual acuity.

Topics Covered in Herpes Simplex Keratitis

Topic 01

Dendritic Ulcers

Topic 02

Immune Stromal Keratitis

Topic 03

HSV Endotheliitis

Topic 04

Acyclovir & Ganciclovir

Topic 05

Recurrence Prophylaxis

Topic 06

Neurotrophic Keratopathy

Related Scientific Sessions at IOC 2027

Why Attend the Herpes Simplex Keratitis Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Herpes Simplex Keratitis work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Herpes Simplex Keratitis research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Herpes Simplex Keratitis track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Herpes Simplex Keratitis Conference 2027 — FAQs

What is the Herpes Simplex Keratitis track at IOC 2027?

The Herpes Simplex Keratitis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Herpes Simplex Keratitis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Herpes Simplex Keratitis sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Herpes Simplex Keratitis are all welcome — whether presenting or attending.

Can I present my research in the Herpes Simplex Keratitis track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Herpes Simplex Keratitis sessions?

Yes. IOC 2027 is a hybrid conference — attend the Herpes Simplex Keratitis track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us